Prosecution Insights
Last updated: April 19, 2026

Examiner: VERKHOVSKY, VANI GUJULUVA

Tech Center 1600 • Art Units: 1655

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
6
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

28.6%
§101 Eligibility
19.1%
§102 Novelty
14.3%
§103 Obviousness
23.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17995938 FOOD EXTRACTS, METHODS OF EXTRACTION AND COMPOSITIONS THEREOF Non-Final OA National University of Singapore
17885279 USE OF BROWN FLAMMULINA VELUTIPES EXTRACT FOR INHIBITING ACUTE KIDNEY INJURY CAUSED BY CISPLATIN Final Rejection ASIA UNIVERSITY
18553575 USE OF MANGOSTEEN FRUIT SHELL EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR TREATING BEDSORES Non-Final OA Xantho Biotechnology Co., LTD
18462749 Active ingredient groups and their key target combinations for the treatment of UC Non-Final OA Centre for Chinese Herbal Medicine Drug Development Limited
18350278 NUTRITIONAL COMPOSITION FOR INHIBITING SURVIVAL OF RNA VIRUS AND METHOD FOR TREATING RNA VIRUS INFECTION Non-Final OA Trade Wind Biotech Co. Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month